In our previous blog, “MARSI Guidelines on Safe Adhesive Removal,” we discuss the one often overlooked hospital acquired condition (HAC) is medical adhesive related skin injury (MARSI). Its prevention should be on every institution’s radar.

In this video, Jack LeDonne, MD, FACS, VA-BC, features a case example of mechanical skin injury related to the removal of an engineered stabilization device followed by a case example of safe adhesive removal with Detachol® Adhesive Remover. Watch below!

Jack LeDonne hails from Brooklyn, NY. He graduated from Fordham University and St. George’s University, School of Medicine, in Grenada. Dr. LeDonne completed his surgical residency at the Wyckoff Heights Hospital, in Brooklyn, and fellowships at the Shock-Trauma Center in Baltimore and Harvard Medical School, Cambridge, Mass. He is presently the medical director at Chesapeake Vascular Access and a partner at Vascular Access Consultants.

Vascular access is Dr. LeDonne’s clinical and research interest. Dr. LeDonne has ten publications, including two videos, to his credit. Jack is a strong believer in the power of video as an educational tool. He is a Fellow of the American College of Surgeons, Vascular Access Board Certified and a past president of the Association for Vascular Access.

For more information about Detachol® Adhesive Remover, please contact your Eloquest Healthcare® sales consultant, or request a follow-up here. Eloquest Healthcare is committed to providing solutions that can help you reduce the risk of conditions like medical adhesive related skin injury (MARSI), central line-associated bloodstream infection (CLABSI) and post-operative wound contamination.